Vertebroplasty and Kyphoplasty Needles Market Size & Growth Forecast 2027–2036, By Segments (End Use, Procedure), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Vertebroplasty and Kyphoplasty Needles Market size was around USD 994.7 million in 2026 and is slated to grow at a 4.66% CAGR from 2027 to 2036, crossing USD 1.57 billion by 2036. The industry revenue for 2027 is calculated at USD 1.03 billion.
Get more details on this report
Request Free Sample ReportVertebroplasty and Kyphoplasty Needles Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 41.76% market share in 2026, supported by high spine procedure volumes, widespread use of minimally invasive treatments, and established hospital purchasing and clinical practices.
- Asia Pacific is forecast to expand at a 5.7% CAGR, driven by increasing adoption of minimally invasive spinal procedures, improving hospital capabilities, and expanding access to interventional spine care.
Segment Momentum
- Hospitals accounted for a 62.69% share in 2026 as they provide integrated imaging, specialist expertise, and perioperative support needed for vertebral compression fracture procedures and complex patient management.
- Kyphoplasty Procedures held a 58.59% share in 2026 while recording the fastest growth due to their established role in minimally invasive vertebral fracture treatment and strong alignment with provider workflow preferences.
Market Expansion Drivers
- Rising spinal injuries from accidents and sports increasing demand for minimally invasive fracture treatments.
- Aging population with osteoporosis driving adoption of vertebral compression fracture procedures.
- Expanding outpatient spine care infrastructure supporting minimally invasive spinal intervention volumes.
Leading Market Participants
- Prominent players in the vertebroplasty and kyphoplasty needles market include Stryker Corporation (United States), Medtronic plc (Ireland), IZI Medical Products (United States), Globus Medical, Inc. (United States), BPB Medica – Biopsybell (Italy), Teknimed S.A.S. (France), Merit Medical Systems, Inc. (United States), ZAVATION Medical Products (United States), RONTIS Corporation (Cyprus).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 994.7 million
- 2027 Estimated Market Size: USD 1.03 billion.
- Projected Market Size: USD 1.57 billion by 2036
- Growth Forecast: 4.66% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End Use) | Kyphoplasty Procedures (Procedure)
- Emerging Opportunity Segment: Ambulatory Surgical Centers (End Use) | Kyphoplasty Procedures (Procedure)
Market Growth Drivers and Industry Trends
Rising spinal injuries from accidents and sports increasing demand for minimally invasive fracture treatments
The increasing incidence of spinal injuries associated with road accidents, sports activities, and other physical trauma will drive the vertebroplasty and kyphoplasty needles market by strengthening demand for less invasive fracture management approaches. Vertebral injuries can cause substantial pain and mobility limitations, encouraging clinicians to consider procedures that stabilize affected vertebrae while reducing surgical trauma. The availability of specialized needles for controlled cement delivery and vertebral augmentation supports efficient intervention in appropriate fracture cases, particularly when faster recovery and reduced hospitalization are important treatment considerations.
Aging population with osteoporosis driving adoption of vertebral compression fracture procedures
An expanding elderly population with osteoporosis is creating a larger patient base vulnerable to vertebral compression fractures, supporting the vertebroplasty and kyphoplasty needles market through greater procedural utilization. Reduced bone density increases the likelihood of vertebral damage from relatively minor physical stress, often resulting in pain, reduced mobility, and difficulties with daily activities. As clinicians focus on restoring vertebral stability and improving functional outcomes, demand for specialized procedural tools is increasing alongside the use of minimally invasive approaches for managing osteoporotic spinal fractures.
Expanding outpatient spine care infrastructure supporting minimally invasive spinal intervention volumes
The development of outpatient spine care facilities is improving access to minimally invasive spinal interventions and will propel the vertebroplasty and kyphoplasty needles market by enabling more procedures to be performed outside traditional inpatient environments. Advances in imaging, procedural monitoring, and post-treatment care allow suitable patients to receive vertebral augmentation with shorter clinical stays. Growing availability of specialized spine centers and ambulatory treatment capabilities also enables healthcare providers to manage selected fracture cases more efficiently while maintaining procedural precision and patient monitoring.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising spinal injuries from accidents and sports increasing demand for minimally invasive fracture treatments | 1.80% | Moderate | North America, Europe | High | Near Term |
| Aging population with osteoporosis driving adoption of vertebral compression fracture procedures | 1.70% | High | North America, Asia Pacific | High | Mid Term |
| Expanding outpatient spine care infrastructure supporting minimally invasive spinal intervention volumes | 1.40% | Moderate | Europe, Asia Pacific | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
In the vertebroplasty and kyphoplasty needles market, North America held the largest share of 41.76% in 2026, supported by advanced healthcare infrastructure, strong adoption of minimally invasive spinal procedures, and the region's established capacity for interventional pain management and orthopedic care. Demand is reinforced by the growing need to address vertebral compression fractures, particularly among aging populations, while well-developed hospital networks and access to specialized physicians facilitate the use of vertebral augmentation techniques. Continued clinical acceptance of minimally invasive treatment approaches and investments in advanced diagnostic and procedural technologies further strengthen the region's commercial position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, driven by expanding healthcare infrastructure, improving access to specialized orthopedic and spinal care, and rising awareness of minimally invasive treatment options. Increasing healthcare investment across developing economies is supporting the modernization of hospitals and procedural facilities, while the growing burden of age-related spinal disorders is creating a broader patient base for vertebral augmentation procedures. Improvements in physician training, diagnostic capabilities, and access to advanced medical devices are also expected to support wider adoption of vertebroplasty and kyphoplasty needles across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Procedure Quality EmphasisGermany prioritizes vertebroplasty and kyphoplasty needles that align with high procedural standards and specialist clinical practice. Hospitals in Germany value dependable device performance and compatibility with image-guided spine interventions.
France 🇫🇷
Specialist Spine ProceduresFrance maintains demand for vertebroplasty and kyphoplasty needles through specialized spinal intervention services. Healthcare facilities in France prioritize reliable procedural instruments that support efficient treatment of vertebral compression fractures.
Italy 🇮🇹
Interventional Orthopedic SupportItaly continues strengthening minimally invasive spine care through consistent adoption of vertebroplasty and kyphoplasty procedures. Hospitals in Italy focus on dependable needle systems that complement imaging-guided workflows and established orthopedic treatment practices.
Japan 🇯🇵
Elderly Spine TreatmentJapan's aging population supports continued use of vertebroplasty and kyphoplasty needles for managing osteoporotic vertebral fractures. Healthcare providers in Japan emphasize precise devices that facilitate efficient minimally invasive spinal procedures.
South Korea 🇰🇷
Advanced Imaging IntegrationSouth Korea favors vertebroplasty and kyphoplasty needles designed for accurate placement within image-guided interventional procedures. Spine specialists in South Korea continue adopting technologies that support procedural consistency and patient-focused treatment pathways.
United States 🇺🇸
Minimally Invasive Spine CareThe U.S. market emphasizes vertebroplasty and kyphoplasty needles that support minimally invasive treatment of vertebral compression fractures. Healthcare providers in the U.S. continue adopting specialized procedural tools that improve precision and procedural efficiency.
Segment Leadership and Growth Trends
Vertebroplasty and Kyphoplasty Needles Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals held the largest share of the vertebroplasty and kyphoplasty needles market at 62.69% in 2026, reflecting their established role in treating patients requiring minimally invasive spinal procedures. Hospitals provide access to specialized imaging, interventional expertise, surgical infrastructure, and multidisciplinary care, making them well suited for procedures involving vertebral compression fractures. The increasing focus on minimally invasive approaches for pain relief and spinal stabilization further supports demand for these needles within hospital settings.
Ambulatory surgical centers are expected to represent the fastest-growing end-use segment as healthcare providers increasingly seek efficient settings for procedures that can be performed without prolonged inpatient stays. The shift toward outpatient care is supported by efforts to improve procedural efficiency, reduce healthcare resource utilization, and enhance patient convenience. Advances in minimally invasive techniques and imaging-guided interventions are further facilitating the use of vertebroplasty and kyphoplasty procedures in ambulatory environments.
Procedure Segment Analysis: Kyphoplasty Procedures (Largest & Fastest-Growing Segment)
Kyphoplasty procedures dominated the vertebroplasty and kyphoplasty needles market, accounting for 58.59% in 2026, while also representing the fastest-growing procedure segment. Their strong position is supported by the ability to stabilize weakened vertebrae and address pain associated with vertebral compression fractures through a minimally invasive approach. Kyphoplasty can also support restoration of vertebral structure and improve patient mobility, making it an important treatment option as demand for less invasive spinal interventions increases. Greater adoption of image-guided procedures, advancements in procedural techniques, and the growing need for effective management of age-related spinal conditions are reinforcing its market momentum.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Ambulatory Surgical Centers | Hospitals | Ambulatory Surgical Centers |
| Procedure | Kyphoplasty Procedures, Vertebroplasty Procedures, Directional Vertebroplasty Needles, Straight Vertebroplasty Needles | Kyphoplasty Procedures | Kyphoplasty Procedures |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the vertebroplasty and kyphoplasty needles market:
1. Stryker Corporation (United States)
2. Medtronic plc (Ireland)
3. IZI Medical Products (United States)
4. Globus Medical Inc. (United States)
5. BPB Medica – Biopsybell (Italy)
6. Teknimed S.A.S. (France)
7. Merit Medical Systems Inc. (United States)
8. ZAVATION Medical Products (United States)
9. RONTIS Corporation (Cyprus)
The vertebroplasty and kyphoplasty needles market is witnessing advancements in minimally invasive spinal treatment technologies and precision-guided procedural tools. Manufacturers are developing ergonomically optimized needle systems that improve accuracy, handling, and patient outcomes during vertebral augmentation procedures. Increasing prevalence of osteoporosis-related spinal disorders is further contributing to market expansion.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Stryker Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| IZI Medical Products (United States) | |||||||
| Globus Medical Inc. (United States) | |||||||
| BPB Medica – Biopsybell (Italy) | |||||||
| Teknimed S.A.S. (France) | |||||||
| Merit Medical Systems Inc. (United States) | |||||||
| ZAVATION Medical Products (United States) | |||||||
| RONTIS Corporation (Cyprus). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Stryker | Aug-24 | Stryker signed a definitive agreement to acquire Vertos Medical, a specialist in minimally invasive spine solutions. This acquisition is designed to integrate the "mild" procedure for lumbar spinal stenosis into Stryker's interventional spine portfolio, offering a comprehensive suite of solutions for chronic back pain management. |
| IZI Medical Products | Aug-21 | IZI Medical Products launched Vertefix HV, a high-viscosity bone cement featuring proprietary "Insite" tracking beads. This product innovation provides surgeons with real-time visualization of cement flow during vertebroplasty and kyphoplasty, enhancing procedural safety and accuracy in stabilizing vertebral fractures. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Vertebroplasty and Kyphoplasty Needles Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Indication | Osteoporotic Vertebral Compression Fractures, Traumatic Vertebral Fractures, Pathological Vertebral Fractures, Vertebral Fractures Associated With Cancer |
| Material | Stainless Steel, Nitinol, Titanium, Other Materials |
| Distribution Channel | Direct Sales, Medical Device Distributors, Group Purchasing Organizations |
Vertebroplasty and Kyphoplasty Needles Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Procedure Adoption and Clinical Practice Evolution |
|
| Hospital Procurement and Reimbursement Landscape |
|
| Emerging Technology Pathways in Vertebral Augmentation |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of vertebroplasty and kyphoplasty needles?
How is the vertebroplasty and kyphoplasty needles industry size expected to evolve during the forecast period?
How are rising trauma-related spinal injuries influencing demand in the vertebroplasty and kyphoplasty needles market?
Why is outpatient spine care expansion increasing adoption of vertebroplasty and kyphoplasty needle systems?
Why are hospitals the largest end users of vertebroplasty and kyphoplasty needles?
Why are Kyphoplasty Procedures the fastest-growing procedure segment in the vertebroplasty and kyphoplasty needles market?
Why does North America lead the vertebroplasty and kyphoplasty needles market?
Which region is projected to grow fastest in the vertebroplasty and kyphoplasty needles market?
Which companies dominate the vertebroplasty and kyphoplasty needles landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization